Also known as: Hodgkin lymphoma, Hodgkin’s lymphoma, Hodgkin disease, Hodgkin’s disease, non-Hodgkin lymphoma, non-Hodgkin’s lymphoma, NHL.
What are Lymphomas?
Lymphomas are a group of blood cell cancers/tumors that start in cells that are part of the body’s immune/lymphatic system (which play an important role in fighting off infection), that then multiply creating a tumor mass in the body. The tumor cells can spread to the rest of the body.
The two main groups of lymphoma are Hodgkin and non-Hodgkin forms (about 90% of cases). The World Health Organization includes two other categories as types of lymphomas: multiple myeloma and immunoproliferative disease.
There are many subtypes that can impact a child’s body, and the difference is related to the cells that are involved. Tumors and their cells can spread throughout the body through the lymph system as well as to other types of tissue within the body.
What causes lymphomas in children?
Lymphoma appears to be related to a genetic mutation. In some cases, this can be passed along from parents to children.
Some environmental factors can increase one’s risk of getting lymphoma, such as certain viral diseases, problems with one’s immune system or exposure to radiation or other hazardous chemicals and medications.
What are the symptoms of lymphoma?
Signs and symptoms of lymphoma may include:
- painless swelling of lymph nodes in one's armpits, neck or groin
- night sweats
- loss of appetite
- weight loss
What are lymphoma care options?
Treatment may include one or more of the following: chemotherapy, radiation therapy and other drugs known as biological therapy (targeted therapy).
Blood or bone marrow transplant is reserved for patients at high risk or those with recurrent disease.
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: April 04, 2022 04:46 PM
June 10, 2021 – Nicklaus Children's Hospital is one of the only hospitals in Florida, and the first pediatric hospital in South Florida, to offer the latest immune cell treatment for children and adolescents with certain types of leukemia. The Cancer and Blood Disorders Institute at Nicklaus Children's Hospital is authorized to deliver the FDA-approved CAR T-cell therapy to the pediatric population.